Literature DB >> 16973162

Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke.

Chuanhui Yu1, Abba J Kastin, Yuemin Ding, Weihong Pan.   

Abstract

Gamma glutamyl transpeptidase (gammaGT) is enriched at the apical surface of the cerebral capillaries that constitute the blood-brain barrier (BBB). This study tested the effects of hypoxia and inflammation on gammaGT activity in mice after stroke induced by transient cerebral artery occlusion (tMCAO) and in cultured cerebral microvessel endothelial cells. In microvessel-enriched preparations from mice after tMCAO, gammaGT activity was higher than in the sham controls in both ipsilateral and contralateral hemispheres from 12 h to 5 days after stroke, but lower at later time points (10-15 days). To identify the roles of different cytotoxic and stimulatory signals in this event, we further studied the dynamic changes of gammaGT activity in rat brain endothelial (RBE4) cells. Tumor necrosis factor alpha and lipopolyssachride significantly increased gammaGT activity in a time-dependent manner, an effect not seen after re-oxygenation. Such endothelial activation correlated with reduced total cellular ATP production. Thus, hypoxia and inflammatory stimulation appeared to have opposite effects on endothelial function. With the co-existence of inflammation and hypoxia in the brain after ischemic stroke, dynamic changes of gammaGT activity reflect evolving changes of endothelial function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973162     DOI: 10.1016/j.expneurol.2006.07.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

1.  Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Yuping Wang; Chuanhui Yu; Weihong Pan
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-25       Impact factor: 6.200

2.  Effects of cell-type specific leptin receptor mutation on leptin transport across the BBB.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; Emily N Markadakis; Kirsten P Stone; Yuping Wang; Steven B Heymsfield; Streamson S Chua; Silvana Obici; I Jack Magrisso; Weihong Pan
Journal:  Peptides       Date:  2011-05-17       Impact factor: 3.750

3.  NFĸB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia.

Authors:  Kirsten P Stone; Abba J Kastin; Weihong Pan
Journal:  Cell Physiol Biochem       Date:  2011-08-16

4.  Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF.

Authors:  Chuanhui Yu; Abba J Kastin; Hong Tu; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

5.  Urocortin trafficking in cerebral microvessel endothelial cells.

Authors:  Hong Tu; Abba J Kastin; Christian Bjorbaek; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  Neuroinflammation facilitates LIF entry into brain: role of TNF.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Yan Zhang; Abba J Kastin
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-02       Impact factor: 4.249

7.  Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS.

Authors:  Weihong Pan; Hung Hsuchou; Chuanhui Yu; Abba J Kastin
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice.

Authors:  Weihong Pan; Hung Hsuchou; Yi He; Amul Sakharkar; Courtney Cain; Chuanhui Yu; Abba J Kastin
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

9.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

10.  Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway.

Authors:  Yan Zhang; Xiaojun Wu; Yi He; Abba J Kastin; Hung Hsuchou; Charles I Rosenblum; Weihong Pan
Journal:  J Neurochem       Date:  2009-05-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.